Market Overview

SAGE Therapeutics Announces Positive End-of-Phase 2 Meeting With FDA, Planned Initiation of SAGE-547 Global Phase 3 Trial in Mid-2015

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News FDA Press Releases

 

Related Articles (SAGE)